Načítá se...
Biologics in inflammatory bowel disease: what are the data?
BACKGROUND: Over the last decade, biologics have gained an important place for the treatment of moderate to severe inflammatory bowel disease (IBD), and many randomized control trials have evaluated their efficacy. AIM: The goal of this review is to analyze the results of these trials and to highlig...
Uloženo v:
| Vydáno v: | United European Gastroenterol J |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
SAGE Publications
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4625751/ https://ncbi.nlm.nih.gov/pubmed/26535119 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050640615590302 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|